GENXGenix Pharmaceuticals Corporation

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · genixpharm.com

0.0200CAD0.00%Mkt Cap: 891742 $P/E: —3d ago

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescri…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap891.74K $

Enterprise Value1.50M $

Revenue (TTM)—

Gross Profit0 $

Net Income (TTM)-244.01K $

Revenue/Share—

Last Price0.0200 CAD

Fiscal Year EndOct 2025

MR QuarterApr 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-0.60

EPS (TTM)-0.01

EPS (Forward)—

52W Range

0.015020% of range0.0400

52W High0.0400 CAD

52W Low0.0150 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE23.61%

ROA-657.16%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-90.36K $

CapEx (TTM)—

FCF Margin—

FCF Yield-13.15%

Net Debt831.87K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-0.73

Current Ratio0.02

Quick Ratio0.01

Book Value/Sh-0.0250 CAD

Cash/Share0.0000 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.61.22M

Float33.41M

Insiders46.92%

Institutions0.00%

Short Interest

Short Ratio1.6d

Short % Out.0.00%

Shares Short760

Short (prev mo.)760

Technical

SMA 500.0200 (-0.0%)

SMA 2000.0229 (-12.7%)

Beta0.40

S&P 52W Chg18.16%

Avg Vol (30d)100

Avg Vol (10d)0

Technical Indicators

RSI (14)51.8

MACD0.0000

MACD Signal0.0000

MACD Hist.-0.0000

BB Upper0.0200 CAD

BB Middle0.0200 CAD

BB Lower0.0200 CAD

BB Width0.00%

ATR (14)0.0001 CAD

Vol Ratio (20d)—